Tan LE, Tan WHG, Aziz MIA, Koh MS, et al. Assessing the cost-effectiveness of mepolizumab as add-on therapy to standard of care for severe eosinophilic asthma in Singapore. J Asthma 2020 Oct 15:1-16. doi: 10.1080/02770903.2020.1837158.
PMID: 33058740